Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche’s Tecentriq/Avastin combo improves survival in liver cancer

pharmatimesJanuary 14, 2021

Tag: Roche , Tecentriq , Avastin , HCC , Liver cancer

PharmaSources Customer Service